Angela Rylands

557 total citations
20 papers, 367 citations indexed

About

Angela Rylands is a scholar working on Nephrology, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Angela Rylands has authored 20 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Nephrology, 3 papers in General Health Professions and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Angela Rylands's work include Parathyroid Disorders and Treatments (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Angela Rylands is often cited by papers focused on Parathyroid Disorders and Treatments (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Angela Rylands collaborates with scholars based in United Kingdom, United States and France. Angela Rylands's co-authors include Eric A. Ross, Michael D. Rugg, Richard N. Henson, Angela Williams, Moira Cheung, M K Javaid, Leanne M. Ward, Gavin Brown, Karl Insogna and Rafael Pinedo‐Villanueva and has published in prestigious journals such as PLoS ONE, NeuroImage and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Angela Rylands

17 papers receiving 362 citations

Peers

Angela Rylands
Laurence Rotkin United States
Avery A. Rizio United States
Rob van Eijk Netherlands
Prabhjot Kaur India
Daniel Tolédano France
Luiz Armando De Marco Brazil
Stephen Giles United Kingdom
Matthew A Rouse United Kingdom
Ronak Patel Canada
Hiroyo Mabe Japan
Laurence Rotkin United States
Angela Rylands
Citations per year, relative to Angela Rylands Angela Rylands (= 1×) peers Laurence Rotkin

Countries citing papers authored by Angela Rylands

Since Specialization
Citations

This map shows the geographic impact of Angela Rylands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Rylands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Rylands more than expected).

Fields of papers citing papers by Angela Rylands

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Rylands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Rylands. The network helps show where Angela Rylands may publish in the future.

Co-authorship network of co-authors of Angela Rylands

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Rylands. A scholar is included among the top collaborators of Angela Rylands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Rylands. Angela Rylands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linglart, Agnès, Iva Gueorguieva, Jérôme Harambat, et al.. (2025). Health-related quality of life in French pediatric patients with X-linked hypophosphatemia: real-world data from the International XLH Registry. JBMR Plus. 9(10). ziaf142–ziaf142.
2.
Johnson, Ben, et al.. (2025). Health-related quality of life and productivity burden for non-professional caregivers of adults with rare diseases: a real-world study. Orphanet Journal of Rare Diseases. 20(1). 282–282. 1 indexed citations
3.
Saraff, Vrinda, Annemieke M. Boot, Agnès Linglart, et al.. (2024). A patient-centred and multi-stakeholder co-designed observational prospective study protocol: Example of the adolescent experience of treatment for X-linked hypophosphataemia (XLH). PLoS ONE. 19(1). e0295080–e0295080. 1 indexed citations
4.
Guttman‐Yassky, Emma, Ken Igawa, Kenji Kabashima, et al.. (2024). Rocatinlimab Improves Patient-Reported Outcomes in Adults with Moderate-to-Severe Atopic Dermatitis: Results from a Double-Blind Placebo-Controlled Phase 2b Study. Dermatology and Therapy. 14(12). 3351–3366.
5.
Mushtaq, Talat, Sanjay Gupta, Angela Williams, et al.. (2024). Impact of stopping burosumab treatment at the end of skeletal growth in adolescents with X-linked hypophosphatemia (XLH). Bone Reports. 24. 101819–101819. 1 indexed citations
6.
Kamenický, Peter, Karine Briot, Maria Luisa Brandi, et al.. (2023). Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. RMD Open. 9(1). e002676–e002676. 20 indexed citations
7.
Bernaards, Coen, Angela Rylands, Adam Gater, et al.. (2023). Development and Psychometric Validation of the 27 Item Zarit CaregiverInterview for Alzheimer’s Disease (ZCI-AD-27). Current Alzheimer Research. 19(13). 878–891. 1 indexed citations
8.
Williams, Angela, et al.. (2022). Carer burden in rare inherited diseases: a literature review and conceptual model. Orphanet Journal of Rare Diseases. 17(1). 428–428. 27 indexed citations
9.
Javaid, M K, Leanne M. Ward, Rafael Pinedo‐Villanueva, et al.. (2021). Musculoskeletal Features in Adults With X-linked Hypophosphatemia: An Analysis of Clinical Trial and Survey Data. The Journal of Clinical Endocrinology & Metabolism. 107(3). e1249–e1262. 27 indexed citations
10.
Cheung, Moira, et al.. (2021). Patient-Reported Complications, Symptoms, and Experiences of Living With X-Linked Hypophosphatemia Across the Life-Course. Journal of the Endocrine Society. 5(8). bvab070–bvab070. 27 indexed citations
11.
12.
13.
14.
15.
16.
Fuller, Rebecca, et al.. (2015). Establishing Equivalence of Electronic Clinician-Reported Outcome Measures. Therapeutic Innovation & Regulatory Science. 50(1). 30–36. 4 indexed citations
17.
18.
Rylands, Angela, Shane McKie, Rebecca Elliott, J.F.W. Deakin, & Nicholas Tarrier. (2011). A Functional Magnetic Resonance Imaging Paradigm of Expressed Emotion in Schizophrenia. The Journal of Nervous and Mental Disease. 199(1). 25–29. 15 indexed citations
19.
Rylands, Angela, Rainer Hinz, Matthew Jones, et al.. (2010). Serotonergic abnormalities in males with extreme levels of impulsive aggression, investigated using 11C-DASB and 11C-MDL100907 PET. NeuroImage. 52. S45–S45. 1 indexed citations
20.
Henson, Richard N., et al.. (2004). The effect of repetition lag on electrophysiological and haemodynamic correlates of visual object priming. NeuroImage. 21(4). 1674–1689. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurence Rotkin Breakdown of academic impact, for papers by Avery A. Rizio Breakdown of academic impact, for papers by Rob van Eijk Breakdown of academic impact, for papers by Prabhjot Kaur Breakdown of academic impact, for papers by Daniel Tolédano Breakdown of academic impact, for papers by Luiz Armando De Marco Breakdown of academic impact, for papers by Stephen Giles Breakdown of academic impact, for papers by Matthew A Rouse Breakdown of academic impact, for papers by Ronak Patel Breakdown of academic impact, for papers by Hiroyo Mabe
Rankless by CCL
2026